GlassScriptPhysician profile
Michael W Grabowski
NPI 1730180597
$14,484.93
in general payments reported to CMS, 2019-2025
15 companies · $2,002 in 2025
The $2,002 reported for 2025 was more than what 82% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $830 · 2020: $189 · 2021: $336 · 2022: $10K · 2023: $446 · 2024: $511 · 2025: $2,002.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,143 · Travel and Lodging: $1,047 · Education: $770.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,142.59 |
| Travel and Lodging | $1,046.84 |
| Education | $770.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,905.44 | 2019-2025 | Da Vinci Surgical System |
| Tela Bio, INC. | $143.29 | 2022-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Davol INC. | $106.25 | 2019 | |
| W. L. Gore & Associates, INC. | $87.27 | 2024 | Gore Enform Preperitoneal Biomaterial |
| Mallinckrodt Enterprises LLC | $45.61 | 2019 | |
| Merck Sharp & Dohme LLC | $35.01 | 2021-2024 | Bridion |
| Ethicon US, LLC | $27.54 | 2019-2020 | |
| Acell, INC. | $24.48 | 2019 | |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Convatec INC. | $17.73 | 2019 | |
| Aesculap, INC. | $16.91 | 2019 | |
| Abbvie INC. | $15.27 | 2023 | |
| Boston Scientific Corporation | $13.70 | 2022 | |
| Asensus Surgical, INC. | $13.35 | 2019 | |
| Olympus America INC. | $13.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Grabowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.